AI models can simulate different stages of human life
He talks about using artificial intelligence in early-stage drug discovery, longevity therapeutics, and how Insilico's AI model can simulate different life stages.
in a CNBC interview after the Hong Kong IPO
Where it comes from
Insilico to use IPO funds to scale up AI drug discovery, says CEOWhat the article says
Alex Zhavoronkov, Founder and CEO of generative-AI drug discovery firm Insilico Medicine, discusses the company's plans after it raised $293 million in its initial public offering in Hong Kong. He ...
CNBC